XAIR - Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference | Benzinga
GARDEN CITY, N.Y., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ:XAIR) ("Beyond Air" or the "Company") a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders and solid tumors (through its affiliate Beyond Cancer, Ltd. ("Beyond Cancer")), today announced that Steve Lisi, Chairman and Chief Executive Officer of Beyond Air, will participate in a fireside discussion and one-on-one meetings at the Piper Sandler Healthcare Conference being held November 28-30, 2023 in New York City.
| Fireside Discussion Details: |
| Title: |
| Beyond Air (NASDAQ:XAIR) Fireside Discussion |
| Date: |
| Thursday, November 30th at 12:30 – 12:55 ET |
| Participants: |
| Steve Lisi, Chairman & CEO, Beyond Air |
| Webcast: |
| https://event.webcasts.com/starthere.jsp?ei=1643872&tp_key=683298e479 |
If you are interested in requesting a one-on-one meeting at the conference, please contact your Piper Sandler representative.
About Beyond Air®, Inc.
Beyond Air is a commercial stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval for its first system, LungFit® PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. Beyond Air is currently advancing ...